Plasma levels of sRANKL and OPG are associated with atherogenic cytokines in patients with intermediate cardiovascular risk

Raaz-Schrauder, D; Schrauder, MG; Stumpf, C; Lewczuk, P; Kilian, T; Dietel, B; Garlichs, CD; Schlundt, C; Achenbach, S; Klinghammer, L

Raaz-Schrauder, D (reprint author), Friedrich Alexander Univ Erlangen Nurnberg FAU, Erlangen Univ Hosp, Dept Cardiol & Angiol, Ulmenweg 18, D-91054 Erlangen, Germany.

HEART AND VESSELS, 2017; 32 (11): 1304

Abstract

Osteoprotegerin (OPG) and receptor activator of nuclear factor-kappa B ligand (RANKL) are regulators of bone remodeling, but are also considered to pl......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索